APO RESEARCH · REPORT
Pharmacy Benefit Management (PBM)
Pharmacy benefit manager (PBM) is a third-party administrator (TPA) of prescription drug programs for commercial health plans, self-insured employer plans, Medicare Part D plans, the Federal Employees Health Benefits Program, and state government employee plans.
Product & engineering
Understand the product.
Pharmacy benefit manager (PBM) is a third-party administrator (TPA) of prescription drug programs for commercial health plans, self-insured employer plans, Medicare Part D plans, the Federal Employees Health Benefits Program, and state government employee plans.
They operate inside of integrated healthcare systems, as part of retail pharmacies, and as part of insurance companies.
Selected research
Market Outlook & Growth Opportunities
Global Pharmacy Benefit Management (PBM) Market Outlook and Growth Opportunities 2026
Market perspective
Pharmacy benefit manager (PBM) is a third-party administrator (TPA) of prescription drug programs for commercial health plans, self-insured employer plans, Medicare Part D plans, the Federal Employees Health Benefits Program, and state government employee plans.
They operate inside of integrated healthcare systems, as part of retail pharmacies, and as part of insurance companies.
Three major PBMs maufacturters include Express Scripts, CVS Health, and OptumRx of UnitedHealth Group, which comprise 75% of the market.
Read the full market overview
USA region is enjoying the largest market share of Pharmacy Benefit Management (PBM), with a market share nearly 97%. EU is the second place of Pharmacy Benefit Management (PBM), enjoying market share nearly 2%.
This report provides an overview of the global Pharmacy Benefit Management (PBM) market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Pharmacy Benefit Management (PBM) and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Pharmacy Benefit Management (PBM) revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Pharmacy Benefit Management (PBM) market.
Pharmacy Benefit Management (PBM) Segment by Company
CVS Health (CVS)
Express Scripts
OptumRx (UnitedHealth)
Humana Pharmacy Solutions
Prime Therapeutics
Medimpact Healthcare
Magellan Health
BC/BS
Vidalink
Sea Rainbow
Cachet
Pharmacy Benefit Management (PBM) Segment by Type
Commercial Health Plans
Self-insured Employer Plans
Medicare Part D plans
Federal Employees Health Benefits Program
State Government Employee Plans
Pharmacy Benefit Management (PBM) Segment by Application
Mail-order Pharmacy Services
Non-mail Pharmacy Services
Pharmacy Benefit Management (PBM) Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Pharmacy Benefit Management (PBM) status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Pharmacy Benefit Management (PBM) key companies, revenue, market share, and recent developments.
3. To split the Pharmacy Benefit Management (PBM) breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Pharmacy Benefit Management (PBM) market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Pharmacy Benefit Management (PBM) significant trends, drivers, influence factors in global and regions.
6. To analyze Pharmacy Benefit Management (PBM) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmacy Benefit Management (PBM) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharmacy Benefit Management (PBM) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmacy Benefit Management (PBM).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pharmacy Benefit Management (PBM) industry.
Chapter 3: Detailed analysis of Pharmacy Benefit Management (PBM) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Pharmacy Benefit Management (PBM) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Pharmacy Benefit Management (PBM) in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Commercial Health Plans
- Self-insured Employer Plans
- Medicare Part D plans
- Federal Employees Health Benefits Program
- State Government Employee Plans
Applications
- Mail-order Pharmacy Services
- Non-mail Pharmacy Services
Companies covered
- CVS Health (CVS)
- Express Scripts
- OptumRx (UnitedHealth)
- Humana Pharmacy Solutions
- Prime Therapeutics
- Medimpact Healthcare
- Magellan Health
- BC/BS
- Vidalink
- Sea Rainbow
- Cachet
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Pharmacy Benefit Management (PBM) Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Pharmacy Benefit Management (PBM) Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Pharmacy Benefit Management (PBM) Market Dynamics
- 2.1 Pharmacy Benefit Management (PBM) Industry Trends
- 2.2 Pharmacy Benefit Management (PBM) Industry Drivers
- 2.3 Pharmacy Benefit Management (PBM) Industry Opportunities and Challenges
- 2.4 Pharmacy Benefit Management (PBM) Industry Restraints
3 Pharmacy Benefit Management (PBM) Market by Company
- 3.1 Global Pharmacy Benefit Management (PBM) Company Revenue Ranking in 2025
- 3.2 Global Pharmacy Benefit Management (PBM) Revenue by Company (2021-2026)
- 3.3 Global Pharmacy Benefit Management (PBM) Company Ranking (2024-2026)
- 3.4 Global Pharmacy Benefit Management (PBM) Company Manufacturing Base and Headquarters
- 3.5 Global Pharmacy Benefit Management (PBM) Company Product Type and Application
- 3.6 Global Pharmacy Benefit Management (PBM) Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Pharmacy Benefit Management (PBM) Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Pharmacy Benefit Management (PBM) Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Pharmacy Benefit Management (PBM) Market by Type
- 4.1 Pharmacy Benefit Management (PBM) Type Introduction
- 4.1.1 Commercial Health Plans
- 4.1.2 Self-insured Employer Plans
- 4.1.3 Medicare Part D plans
- 4.1.4 Federal Employees Health Benefits Program
- 4.1.5 State Government Employee Plans
- 4.2 Global Pharmacy Benefit Management (PBM) Sales Value by Type
- 4.2.1 Global Pharmacy Benefit Management (PBM) Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Pharmacy Benefit Management (PBM) Sales Value by Type (2021-2032)
- 4.2.3 Global Pharmacy Benefit Management (PBM) Sales Value Share by Type (2021-2032)
5 Pharmacy Benefit Management (PBM) Market by Application
- 5.1 Pharmacy Benefit Management (PBM) Application Introduction
- 5.1.1 Mail-order Pharmacy Services
- 5.1.2 Non-mail Pharmacy Services
- 5.2 Global Pharmacy Benefit Management (PBM) Sales Value by Application
- 5.2.1 Global Pharmacy Benefit Management (PBM) Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Pharmacy Benefit Management (PBM) Sales Value by Application (2021-2032)
- 5.2.3 Global Pharmacy Benefit Management (PBM) Sales Value Share by Application (2021-2032)
6 Pharmacy Benefit Management (PBM) Regional Value Analysis
- 6.1 Global Pharmacy Benefit Management (PBM) Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Pharmacy Benefit Management (PBM) Sales Value by Region (2021-2032)
- 6.2.1 Global Pharmacy Benefit Management (PBM) Sales Value by Region: 2021-2026
- 6.2.2 Global Pharmacy Benefit Management (PBM) Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Pharmacy Benefit Management (PBM) Sales Value (2021-2032)
- 6.3.2 North America Pharmacy Benefit Management (PBM) Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Pharmacy Benefit Management (PBM) Sales Value (2021-2032)
- 6.4.2 Europe Pharmacy Benefit Management (PBM) Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Pharmacy Benefit Management (PBM) Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Pharmacy Benefit Management (PBM) Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Pharmacy Benefit Management (PBM) Sales Value (2021-2032)
- 6.6.2 South America Pharmacy Benefit Management (PBM) Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Pharmacy Benefit Management (PBM) Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Pharmacy Benefit Management (PBM) Sales Value Share by Country, 2025 VS 2032
7 Pharmacy Benefit Management (PBM) Country-level Value Analysis
- 7.1 Global Pharmacy Benefit Management (PBM) Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Pharmacy Benefit Management (PBM) Sales Value by Country (2021-2032)
- 7.2.1 Global Pharmacy Benefit Management (PBM) Sales Value by Country (2021-2026)
- 7.2.2 Global Pharmacy Benefit Management (PBM) Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Pharmacy Benefit Management (PBM) Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Pharmacy Benefit Management (PBM) Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Pharmacy Benefit Management (PBM) Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Pharmacy Benefit Management (PBM) Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Pharmacy Benefit Management (PBM) Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Pharmacy Benefit Management (PBM) Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Pharmacy Benefit Management (PBM) Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Pharmacy Benefit Management (PBM) Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Pharmacy Benefit Management (PBM) Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Pharmacy Benefit Management (PBM) Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Pharmacy Benefit Management (PBM) Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Pharmacy Benefit Management (PBM) Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Pharmacy Benefit Management (PBM) Sales Value Growth Rate (2021-2032)
- 7.7.2 France Pharmacy Benefit Management (PBM) Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Pharmacy Benefit Management (PBM) Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Pharmacy Benefit Management (PBM) Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Pharmacy Benefit Management (PBM) Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Pharmacy Benefit Management (PBM) Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Pharmacy Benefit Management (PBM) Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Pharmacy Benefit Management (PBM) Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Pharmacy Benefit Management (PBM) Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Pharmacy Benefit Management (PBM) Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Pharmacy Benefit Management (PBM) Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Pharmacy Benefit Management (PBM) Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Pharmacy Benefit Management (PBM) Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Pharmacy Benefit Management (PBM) Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Pharmacy Benefit Management (PBM) Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Pharmacy Benefit Management (PBM) Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Pharmacy Benefit Management (PBM) Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Pharmacy Benefit Management (PBM) Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Pharmacy Benefit Management (PBM) Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Pharmacy Benefit Management (PBM) Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Pharmacy Benefit Management (PBM) Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Pharmacy Benefit Management (PBM) Sales Value Growth Rate (2021-2032)
- 7.14.2 China Pharmacy Benefit Management (PBM) Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Pharmacy Benefit Management (PBM) Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Pharmacy Benefit Management (PBM) Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Pharmacy Benefit Management (PBM) Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Pharmacy Benefit Management (PBM) Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Pharmacy Benefit Management (PBM) Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Pharmacy Benefit Management (PBM) Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Pharmacy Benefit Management (PBM) Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Pharmacy Benefit Management (PBM) Sales Value Growth Rate (2021-2032)
- 7.17.2 India Pharmacy Benefit Management (PBM) Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Pharmacy Benefit Management (PBM) Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Pharmacy Benefit Management (PBM) Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Pharmacy Benefit Management (PBM) Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Pharmacy Benefit Management (PBM) Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Pharmacy Benefit Management (PBM) Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Pharmacy Benefit Management (PBM) Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Pharmacy Benefit Management (PBM) Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Pharmacy Benefit Management (PBM) Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Pharmacy Benefit Management (PBM) Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Pharmacy Benefit Management (PBM) Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Pharmacy Benefit Management (PBM) Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Pharmacy Benefit Management (PBM) Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Pharmacy Benefit Management (PBM) Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Pharmacy Benefit Management (PBM) Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Pharmacy Benefit Management (PBM) Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Pharmacy Benefit Management (PBM) Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Pharmacy Benefit Management (PBM) Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Pharmacy Benefit Management (PBM) Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Pharmacy Benefit Management (PBM) Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Pharmacy Benefit Management (PBM) Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Pharmacy Benefit Management (PBM) Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Pharmacy Benefit Management (PBM) Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Pharmacy Benefit Management (PBM) Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Pharmacy Benefit Management (PBM) Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Pharmacy Benefit Management (PBM) Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Pharmacy Benefit Management (PBM) Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Pharmacy Benefit Management (PBM) Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Pharmacy Benefit Management (PBM) Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Pharmacy Benefit Management (PBM) Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Pharmacy Benefit Management (PBM) Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Pharmacy Benefit Management (PBM) Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Pharmacy Benefit Management (PBM) Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Pharmacy Benefit Management (PBM) Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Pharmacy Benefit Management (PBM) Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Pharmacy Benefit Management (PBM) Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Pharmacy Benefit Management (PBM) Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Pharmacy Benefit Management (PBM) Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Pharmacy Benefit Management (PBM) Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Pharmacy Benefit Management (PBM) Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Pharmacy Benefit Management (PBM) Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 CVS Health (CVS)
- 8.1.1 CVS Health (CVS) Company Information
- 8.1.2 CVS Health (CVS) Business Overview
- 8.1.3 CVS Health (CVS) Pharmacy Benefit Management (PBM) Revenue and Gross Margin (2021-2026)
- 8.1.4 CVS Health (CVS) Pharmacy Benefit Management (PBM) Product Portfolio
- 8.1.5 CVS Health (CVS) Recent Developments
- 8.2 Express Scripts
- 8.2.1 Express Scripts Company Information
- 8.2.2 Express Scripts Business Overview
- 8.2.3 Express Scripts Pharmacy Benefit Management (PBM) Revenue and Gross Margin (2021-2026)
- 8.2.4 Express Scripts Pharmacy Benefit Management (PBM) Product Portfolio
- 8.2.5 Express Scripts Recent Developments
- 8.3 OptumRx (UnitedHealth)
- 8.3.1 OptumRx (UnitedHealth) Company Information
- 8.3.2 OptumRx (UnitedHealth) Business Overview
- 8.3.3 OptumRx (UnitedHealth) Pharmacy Benefit Management (PBM) Revenue and Gross Margin (2021-2026)
- 8.3.4 OptumRx (UnitedHealth) Pharmacy Benefit Management (PBM) Product Portfolio
- 8.3.5 OptumRx (UnitedHealth) Recent Developments
- 8.4 Humana Pharmacy Solutions
- 8.4.1 Humana Pharmacy Solutions Company Information
- 8.4.2 Humana Pharmacy Solutions Business Overview
- 8.4.3 Humana Pharmacy Solutions Pharmacy Benefit Management (PBM) Revenue and Gross Margin (2021-2026)
- 8.4.4 Humana Pharmacy Solutions Pharmacy Benefit Management (PBM) Product Portfolio
- 8.4.5 Humana Pharmacy Solutions Recent Developments
- 8.5 Prime Therapeutics
- 8.5.1 Prime Therapeutics Company Information
- 8.5.2 Prime Therapeutics Business Overview
- 8.5.3 Prime Therapeutics Pharmacy Benefit Management (PBM) Revenue and Gross Margin (2021-2026)
- 8.5.4 Prime Therapeutics Pharmacy Benefit Management (PBM) Product Portfolio
- 8.5.5 Prime Therapeutics Recent Developments
- 8.6 Medimpact Healthcare
- 8.6.1 Medimpact Healthcare Company Information
- 8.6.2 Medimpact Healthcare Business Overview
- 8.6.3 Medimpact Healthcare Pharmacy Benefit Management (PBM) Revenue and Gross Margin (2021-2026)
- 8.6.4 Medimpact Healthcare Pharmacy Benefit Management (PBM) Product Portfolio
- 8.6.5 Medimpact Healthcare Recent Developments
- 8.7 Magellan Health
- 8.7.1 Magellan Health Company Information
- 8.7.2 Magellan Health Business Overview
- 8.7.3 Magellan Health Pharmacy Benefit Management (PBM) Revenue and Gross Margin (2021-2026)
- 8.7.4 Magellan Health Pharmacy Benefit Management (PBM) Product Portfolio
- 8.7.5 Magellan Health Recent Developments
- 8.8 BC/BS
- 8.8.1 BC/BS Company Information
- 8.8.2 BC/BS Business Overview
- 8.8.3 BC/BS Pharmacy Benefit Management (PBM) Revenue and Gross Margin (2021-2026)
- 8.8.4 BC/BS Pharmacy Benefit Management (PBM) Product Portfolio
- 8.8.5 BC/BS Recent Developments
- 8.9 Vidalink
- 8.9.1 Vidalink Company Information
- 8.9.2 Vidalink Business Overview
- 8.9.3 Vidalink Pharmacy Benefit Management (PBM) Revenue and Gross Margin (2021-2026)
- 8.9.4 Vidalink Pharmacy Benefit Management (PBM) Product Portfolio
- 8.9.5 Vidalink Recent Developments
- 8.10 Sea Rainbow
- 8.10.1 Sea Rainbow Company Information
- 8.10.2 Sea Rainbow Business Overview
- 8.10.3 Sea Rainbow Pharmacy Benefit Management (PBM) Revenue and Gross Margin (2021-2026)
- 8.10.4 Sea Rainbow Pharmacy Benefit Management (PBM) Product Portfolio
- 8.10.5 Sea Rainbow Recent Developments
- 8.11 Cachet
- 8.11.1 Cachet Company Information
- 8.11.2 Cachet Business Overview
- 8.11.3 Cachet Pharmacy Benefit Management (PBM) Revenue and Gross Margin (2021-2026)
- 8.11.4 Cachet Pharmacy Benefit Management (PBM) Product Portfolio
- 8.11.5 Cachet Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst